These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30124945)

  • 1. Toll-Like Receptor 4 as an Immune Receptor Against Mycobacterium tuberculosis: A Systematic Review.
    Sepehri Z; Kiani Z; Kohan F; Ghavami S
    Lab Med; 2019 Apr; 50(2):117-129. PubMed ID: 30124945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of TLR4 and TLR8 in the Innate Immune Response against Mycobacterium Tuberculosis.
    Thada S; Horvath GL; Müller MM; Dittrich N; Conrad ML; Sur S; Hussain A; Pelka K; Gaddam SL; Latz E; Slevogt H; Schumann RR; Burkert S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557133
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
    Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent
    Park J; Kim H; Kwon KW; Choi HH; Kang SM; Hong JJ; Shin SJ
    Virulence; 2020 Dec; 11(1):430-445. PubMed ID: 32403973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 is non-redundant in the population and subpopulation responses to
    Jani C; Solomon SL; Peters JM; Pringle SC; Hinman AE; Boucau J; Bryson BD; Barczak AK
    mSystems; 2023 Aug; 8(4):e0005223. PubMed ID: 37439558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review.
    Afsharimoghaddam A; Soleimani M; Lashay A; Dehghani M; Sepehri Z
    Life Sci; 2016 Aug; 158():31-6. PubMed ID: 27316642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
    Gopalakrishnan A; Salgame P
    Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIR337-3p Enhances Mycobacterial Pathogenicity Involving TLR4/MYD88 and STAT3 Signals, Impairing VDR Antimicrobial Response and Fast-Acting Immunity.
    Liang S; Huang G; Wu T; Peng Y; Liu X; Ji X; Sha W; Wang F; Shen L; Shen H
    Front Immunol; 2021; 12():739219. PubMed ID: 34912331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to
    Dubé JY; Fava VM; Schurr E; Behr MA
    Front Immunol; 2021; 12():714808. PubMed ID: 34276708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ESAT-6 in renal injury by regulating microRNA-155 expression via TLR4/MyD88 signaling pathway in mice with
    Zhou ZQ; Wang ZK; Zhang L; Ren YQ; Ma ZW; Zhao N; Sun FY
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28655852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.
    Sia JK; Georgieva M; Rengarajan J
    J Immunol Res; 2015; 2015():747543. PubMed ID: 26258152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM; Chan J; Casadevall A
    Immunol Rev; 2015 Mar; 264(1):167-81. PubMed ID: 25703559
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the Process.
    Kim JS; Kim YR; Yang CS
    J Microbiol Biotechnol; 2019 Oct; 29(10):1506-1521. PubMed ID: 31581380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium indicus pranii (MIP) mediated host protective intracellular mechanisms against tuberculosis infection: Involvement of TLR-4 mediated signaling.
    Das S; Chowdhury BP; Goswami A; Parveen S; Jawed J; Pal N; Majumdar S
    Tuberculosis (Edinb); 2016 Dec; 101():201-209. PubMed ID: 27865392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity in tuberculosis: host defense vs pathogen evasion.
    Liu CH; Liu H; Ge B
    Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.
    Faridgohar M; Nikoueinejad H
    Pathog Glob Health; 2017 Jul; 111(5):256-264. PubMed ID: 28715935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.